California Public Employees Retirement System Mirati Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$36.54 - $54.26 $21.3 Million - $31.6 Million	-583,165 Reduced 89.36%	69,454 $2.58 Million
Q4 2022 Feb 08, 2023	BUY	$41.27 - $98.62 $23.1 Million - $55.2 Million	560,034 Added 604.89%	652,619 $29.6 Million
Q3 2022 Nov 09, 2022	BUY	$59.5 - $86.7 $1.11 Million - $1.62 Million	18,660 Added 25.24%	92,585 $6.47 Million
Q2 2022 Aug 10, 2022	SELL	$39.16 - $88.71 $215,575 - $488,348	-5,505 Reduced 6.93%	73,925 $4.96 Million
Q1 2022 May 04, 2022	SELL	$75.82 - $150.97 $336,944 - $670,910	-4,444 Reduced 5.3%	79,430 $6.53 Million
Q4 2021 Feb 10, 2022	BUY	$132.01 - $190.29 $371,608 - $535,666	2,815 Added 3.47%	83,874 $12.3 Million
Q3 2021 Nov 10, 2021	SELL	$132.13 - $177.45 $90,244 - $121,198	-683 Reduced 0.84%	81,059 $14.3 Million
Q2 2021 Aug 13, 2021	SELL	$144.0 - $179.73 $1.42 Million - $1.78 Million	-9,877 Reduced 10.78%	81,742 $13.2 Million
Q1 2021 May 14, 2021	SELL	$158.92 - $221.61 $1.87 Million - $2.61 Million	-11,775 Reduced 11.39%	91,619 $15.7 Million
Q4 2020 Feb 02, 2021	BUY	$162.05 - $240.27 $2.96 Million - $4.39 Million	18,270 Added 21.46%	103,394 $22.7 Million
Q3 2020 Nov 05, 2020	BUY	$113.26 - $167.27 $429,368 - $634,120	3,791 Added 4.66%	85,124 $14.1 Million
Q2 2020 Aug 12, 2020	BUY	$72.01 - $120.39 $1.32 Million - $2.2 Million	18,309 Added 29.05%	81,333 $9.29 Million
Q1 2020 May 12, 2020	SELL	$69.78 - $116.21 $47,310 - $78,790	-678 Reduced 1.06%	63,024 $4.85 Million
Q4 2019 Jan 27, 2020	SELL	$70.76 - $128.86 $558,650 - $1.02 Million	-7,895 Reduced 11.03%	63,702 $8.21 Million
Q3 2019 Oct 31, 2019	BUY	$77.91 - $109.6 $1.84 Million - $2.58 Million	23,580 Added 49.11%	71,597 $5.58 Million
Q2 2019 Aug 15, 2019	BUY	$59.49 - $104.71 $60,441 - $106,385	1,016 Added 2.16%	48,017 $4.95 Million
Q1 2019 May 03, 2019	SELL	$43.65 - $78.95 $17,460 - $31,580	-400 Reduced 0.84%	47,001 $3.45 Million
Q4 2018 Feb 08, 2019	BUY	$32.0 - $47.43 $800,000 - $1.19 Million	25,000 Added 111.6%	47,401 $2.01 Million
Q3 2018 Nov 13, 2018	BUY	$47.1 - $62.7 $1.06 Million - $1.4 Million	22,401 New	22,401 $1.06 Million
Q2 2018 Aug 15, 2018	SELL	$26.05 - $52.4 $233,043 - $468,770	-8,946 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$17.2 - $34.95 $153,871 - $312,662	8,946 New	8,946 $275,000

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account